CYTALUX™ (pafolacianine): Clinical Trials

2 trials of CYTALUX™ (pafolacianine), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Phase 41Recruiting 1

Follow CYTALUX™ (pafolacianine): new trials by email Literature Review of CYTALUX™ (pafolacianine) trials Research Report on CYTALUX™ (pafolacianine)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
CYTALUX™ (pafolacianine), 1788 4K Camera System with Advanced Imaging Modality - Endometrial Cancer, Near Infrared Fluorescence Imaging
Early Phase 1RecruitingAbramson Cancer Center at Penn Medicine102025-10-182025-12-12
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
CYTALUX™ (pafolacianine) - Gastrointestinal Cancer, Gastric Cancer
Phase 4RecruitingCedars-Sinai Medical Center152025-09-052025-09-15

Conditions studied

Appendiceal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Stomach Neoplasms (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Cedars-Sinai Medical Center (1)

Countries

United States (2)

Top investigators

Miguel Burch, MD (1)